GMAB:CPH
Genmab
DKKÂ 1Â 607,00
arrow_upward
+1,48%(+23,50) 1D
8 Jun., 15:44:59 GMT+2 · DKK
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GMAB...
Open
DKKÂ 1Â 600,00
High
DKKÂ 1Â 629,00
Low
DKKÂ 1Â 590,50
Mkt. cap
99,39Â mjd
Avg. vol.
179,79Â k
Volume
86,34Â k
52-wk high
DKKÂ 2Â 257,00
52-wk low
DKKÂ 1Â 275,00
Shares outstanding
62,35Â m
No. of employees
3Â k
Open
DKKÂ 1Â 600,00
High
DKKÂ 1Â 629,00
Low
DKKÂ 1Â 590,50
Mkt. cap
99,39Â mjd
Avg. vol.
179,79Â k
Volume
86,34Â k
52-wk high
DKKÂ 2Â 257,00
52-wk low
DKKÂ 1Â 275,00
Shares outstanding
62,35Â m
No. of employees
3Â k
Analyst outlook
Analyst Ratings
Based on 7 analysts giving stock ratings to GMAB in the past 3 months
Strong Buy
Buy
6
Hold
1
Sell
0
12 month forecast
Based on 7 Wall Street analysts offering 12 month price targets for GMAB in the last 3 months.
Highest
Current €1 607,00
Average
€318,25 (-80,20%)
Lowest
€280,98 (-82,52%)
News stories
From sources across the web
DirectorsTalk Interviews
·
4 uur gelede
Genmab A/S (GMAB) Stock Analysis: A 46% Upside Potential That Investors Can’t Ignore
Profile
Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. The company is based in Copenhagen, Denmark – internationally, it operates through the subsidiaries Genmab B.V. in Utrecht, The Netherlands, Genmab U.S., Inc. in Princeton, New Jersey, US, Genmab K.K. in Tokyo, Japan, Genmab Germany GmbH in München, Germany and Genmab Co., Ltd. in Suzhou, China. Genmab is listed on the Copenhagen Stock Exchange in Denmark, with American depositary receipts traded on the NASDAQ in the US. Wikipedia
About Genmab
AI content may include mistakes. Learn more